| 000 | 00796naa a2200241 i 4500 | ||
|---|---|---|---|
| 001 | 22635 | ||
| 003 | ES-MaBCM | ||
| 005 | 20241016094322.0 | ||
| 008 | 930219s1993 gbr 000 0 eng d | ||
| 021 | _axx | ||
| 035 | _a(OCoLC)1365195162 | ||
| 040 | _cES-MaBCM | ||
| 041 | 0 | _aeng | |
| 043 | _agbr | ||
| 110 | 1 |
_aGran Bretaña _952062 _bForeign and Commonwealth Office |
|
| 245 | 1 | 0 |
_aProtocol to the Convention on the Elaboration of a European Pharmacopoeia _b: Strasbourg, 16 November 1989 _cForeign and Commonwealth Office |
| 650 | 2 | 4 |
_aConvención Europea _951085 |
| 655 | 4 |
_aTratado internacional _960525 |
|
| 650 | 7 |
_aEstablecimiento farmacéutico _958688 |
|
| 650 | 2 | 7 |
_aMercado de la UE _959399 |
| 773 | 0 |
_aEn: _tCm _dLondon : 1993 _w104537 _gno. 2140, Feb., p. 1-4 |
|
| 942 | _cAREV | ||
| 999 |
_c22635 _d22635 |
||